Summary & Overview

CPT 1007F: No Summary Available

CPT code 1007F is listed without an accompanying descriptive summary. As a CPT performance or reporting entry, the code’s presence can affect documentation, reporting workflows, and claims adjudication when included in clinical records. National payers and programs routinely rely on accurate CPT coding to support payment, quality measurement, and administrative processing; an undefined or undocumented code entry can create uncertainty for billing teams and payers.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what is known about the code from the provided input, an account of missing data elements, and guidance on the types of benchmarks and policy context typically relevant for CPT entries—such as reimbursement alignment, reporting implications, and clinical documentation needs. This publication does not recommend clinical or billing actions but summarizes the available information and notes where additional data is required for operational use.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare1007FCPTbillingcodingdocumentationclaimsquality-reportinghealthcare-policy

Billing Code Overview

CPT code 1007F has no summary available in the source description. Based on the code entry, the service type and typical site of service are not specified in the input and therefore must be inferred from the code label when present. Service type: Data not available in the input. Typical site of service: Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult presenting to an outpatient dermatology or minor procedure clinic for removal of a benign-appearing, symptomatic, or cosmetically concerning skin lesion. The workflow begins with a brief pre-procedure evaluation documenting lesion location, size, medical history, anticoagulation status, and informed consent. Local anesthesia (typically lidocaine with or without epinephrine) is administered, the lesion is excised or destroyed using a method appropriate to lesion type (shave, excision, cryotherapy, electrocautery, or destructive chemical application), hemostasis is achieved, and a simple dressing is applied. Procedure documentation includes lesion description, technique, anesthesia, estimated blood loss, specimens submitted (if any), and post-procedure care instructions. Typical sites of service are outpatient dermatology clinics, ambulatory surgery centers, and primary care procedure rooms. Common patient scenarios include removal of benign nevi, skin tags, seborrheic keratoses, and superficial non-melanoma lesions for symptomatic relief or diagnostic pathology when indicated.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, Separately Identifiable Evaluation and Management Service by the Same Physician on the Same Day of the Procedure	Use when a distinct E/M is provided on the day of the procedure and must be reported separately.

26

Taxonomy Code	Specialty	Notes
`207N00000X`	Dermatology	Most common specialty performing skin lesion removals and destructions.
`207P00000X`	Plastic Surgery	Performs excisions, especially when complex reconstruction is anticipated.
`207Q00000X`	General Surgery	Performs cutaneous excisions in operative settings for larger lesions.
`207L00000X`	Emergency Medicine	Performs urgent lesion removals or control of bleeding in ED settings.
`261Q00000X`	Family Medicine	Performs office-based minor skin procedures and destructive treatments.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`L82.0`	Seborrheic keratosis	Common benign epidermal lesion frequently removed for cosmetic reasons or irritation.
`L91.8`	Other hypertrophic and atrophic conditions of skin	May apply to certain raised benign lesions considered for removal.
`L57.0`	Actinic keratosis	Premalignant lesions often treated with destructive modalities rather than excision.
`D23.9`	Other benign neoplasm of skin, unspecified	General code for benign skin tumors considered for excision or destruction.
`L91.0`	Keloid scar	Lesions that may be excised or treated when symptomatic or for cosmesis.
`C44.9`	Malignant neoplasm of skin, unspecified	Used when pathology or clinical suspicion necessitates excision and further oncologic management.
`L91.8`	Hypertrophic scarring and other specified conditions	Included for lesions where surgical removal addresses abnormal scarring.
`L90.8`	Other inflammatory disorders of skin	Includes inflammatory lesions that might be surgically managed in some cases.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`10060`	Incision and drainage of abscess; simple or single	Performed when a lesion is an abscess requiring drainage rather than removal.
`11100`	Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion	Used when a diagnostic biopsy is performed instead of or before definitive lesion removal.
`11400`	Excision, benign lesion; trunk, arms or legs; excised diameter 0.5 cm or less	Represents formal excision of benign lesions with size-based coding when full-thickness removal is performed.
`17110`	Destruction, premalignant lesions (e.g., actinic keratoses); first lesion	Used when lesions are treated with destructive modalities such as cryotherapy or electrosurgery.
`99024`	Postoperative follow-up visit, postoperative global period, related to the original procedure	Used for routine postoperative follow-up visits within the global period when applicable.